Skip to main content

Category 2 Peptides

Meaning

In the context of pharmaceutical and regulatory classification, Category 2 Peptides typically refers to a group of peptides that have been deemed by regulatory bodies, such as the FDA, to be of questionable or high risk, or those lacking sufficient clinical data for widespread therapeutic approval. These peptides may exhibit significant pharmacological activity but often fall outside the established, rigorously tested therapeutic categories. They are frequently subjects of ongoing research or may be associated with compounding pharmacy regulations that restrict their preparation and use. Patients should exercise caution and seek expert clinical guidance regarding any compound in this designation.